Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 2
196
Views
10
CrossRef citations to date
0
Altmetric
Original Article

lncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p

Pages 119-127 | Received 27 Apr 2021, Accepted 20 Sep 2021, Published online: 21 Oct 2021

References

  • Chen, M., et al., 2016. High glucose induces mitochondrial dysfunction and apoptosis in human retinal pigment epithelium cells via promoting SOCS1 and Fas/FasL signaling. Cytokine, 78, 94–102.
  • Cui, Y., Xie, M., and Zhang, Z., 2020. LINC00958 involves in bladder cancer through sponging miR-378a-3p to Elevate IGF1R. Cancer Biotherapy & Radiopharmaceuticals, 35 (10), 776–788.
  • Durham, J.T., and Herman, I.M., 2011. Microvascular modifications in diabetic retinopathy. Current Diabetes Reports, 11 (4), 253–264.
  • Dvir, L., et al., 2010. Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase. American Journal of Human Genetics, 87 (2), 258–264.
  • Fenwick, E.K., et al., 2020. Validation of a novel diabetic retinopathy utility index using discrete choice experiments. The British Journal of Ophthalmology, 104 (2), 188–193.
  • Gong, Q., and Su, G., 2017. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy. Bioscience Reports, 37 (6), BSR20171157.
  • Guo, X.B., et al., 2019. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17. Oncology Reports, 42 (5), 1957–1971.
  • Ionita, M.A., and Pittler, S.J., 2007. Focus on molecules: rod cGMP phosphodiesterase type 6. Experimental Eye Research, 84 (1), 1–2.
  • Liu, P., et al., 2019. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Bioscience Reports, 39 (5), BSR20181469.
  • Luo, R., et al., 2020. lncRNA H19 sponging miR-93 to regulate inflammation in retinal epithelial cells under hyperglycemia via XBP1s. Inflammation Research: official Journal of the European Histamine Research Society. [et al.], 69 (3), 255–265.
  • Machado, I.F., et al., 2021. miR-378a-3p participates in metformin's mechanism of action on C2C12 cells under hyperglycemia. International Journal of Molecular Sciences., 22, 541.
  • Monaghan, K., et al., 2015. Hyperglycemia and diabetes downregulate the functional expression of TRPV4 channels in retinal microvascular endothelium. PLoS One, 10 (6), e0128359.
  • Muradov, K.G., Granovsky, A.E., and Artemyev, N.O., 2003. Mutation in rod PDE6 linked to congenital stationary night blindness impairs the enzyme inhibition by its gamma-subunit. Biochemistry, 42 (11), 3305–3310.
  • Quan, L.J., and Wang, W.J., 2019. FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma. Bioscience Reports, 39 (5), BSR20190754.
  • Sakamoto, K., et al., 2009. New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene. Human Molecular Genetics, 18 (1), 178–192.
  • Shan, K., et al., 2017. Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus. Circulation, 136 (17), 1629–1642.
  • Tuntivanich, N., et al., 2009. Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation. Investigative Ophthalmology & Visual Science, 50 (2), 801–813.
  • Wang, M., et al., 2018. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Thoracic Cancer, 9 (8), 939–949.
  • Wang, Y., and Zhang, Q., 2020. Long noncoding RNA MALAT1 knockdown inhibits proliferation, migration, and invasion and promotes apoptosis in non-small-cell lung cancer cells through regulating miR-515-3p/TRIM65 axis. Cancer Biotherapy and Radiopharmaceuticals. [10.1089/cbr.2020.3730]
  • Yau, J.W., et al., 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35 (3), 556–564.
  • Ye, M., et al., 2021. Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204/IGF2BP2/m6A-MYC signaling. Molecular Therapy. Nucleic Acids, 23, 1–12.
  • Ye, Z., Li, Z., and He, S., 2017. Long non‑coding RNA associated‑competing endogenous RNAs are induced by clusterin in retinal pigment epithelial cells. Molecular Medicine Reports, 16 (6), 8399–8405.
  • You, Z.P., et al., 2018. Bioinformatics analysis of weighted genes in diabetic retinopathy. Investigative Ophthalmology and Visual Science, 59 (13), 5558–5563.
  • Yu, L., et al., 2020. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p. Canadian Journal of Physiology and Pharmacology, 98 (4), 219–227.
  • Zhang, C., and Wu, S., 2020. microRNA -378a-3p restrains the proliferation of retinoblastoma cells but promotes apoptosis of retinoblastoma cells via inhibition of FOXG1. Investigative Ophthalmology & Visual Science, 61 (5), 31.
  • Zhang, D., et al., 2018. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. Experimental and Therapeutic Medicine, 16 (3), 2337–2342.
  • Zhang, J., et al., 2017. Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing miR-29b and regulating cell apoptosis. Bioscience Reports, 37 (2), BSR20170036.
  • Zhu, B., Cui, H., and Xu, W., 2021. Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis. Cancer Cell International, 21 (1), 70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.